Annual Total Expenses:
$453.25M+$18.13M(+4.17%)Summary
- As of today, BCRX annual total expenses is $453.25 million, with the most recent change of +$18.13 million (+4.17%) on December 31, 2024.
- During the last 3 years, BCRX annual total expenses has risen by +$118.36 million (+35.34%).
- BCRX annual total expenses is now at all-time high.
Performance
BCRX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Expenses:
$146.50M-$11.77M(-7.44%)Summary
- As of today, BCRX quarterly total expenses is $146.50 million, with the most recent change of -$11.77 million (-7.44%) on September 30, 2025.
- Over the past year, BCRX quarterly total expenses has increased by +$15.38 million (+11.73%).
- BCRX quarterly total expenses is now -7.47% below its all-time high of $158.33 million, reached on December 31, 2024.
Performance
BCRX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
BCRX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +4.2% | +11.7% |
| 3Y3 Years | +35.3% | +23.8% |
| 5Y5 Years | +205.7% | +180.6% |
BCRX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +35.3% | -7.5% | +23.8% |
| 5Y | 5-Year | at high | +205.7% | -7.5% | +180.6% |
| All-Time | All-Time | at high | +5943.4% | -7.5% | >+9999.0% |
BCRX Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $146.50M(-7.4%) |
| Jun 2025 | - | $158.27M(+8.8%) |
| Mar 2025 | - | $145.50M(-8.1%) |
| Dec 2024 | $453.25M(+4.2%) | $158.33M(+20.8%) |
| Sep 2024 | - | $131.12M(+7.5%) |
| Jun 2024 | - | $122.01M(-4.8%) |
| Mar 2024 | - | $128.14M(-17.4%) |
| Dec 2023 | $435.12M(+3.8%) | $155.13M(+26.2%) |
| Sep 2023 | - | $122.89M(-22.1%) |
| Jun 2023 | - | $157.82M(+29.2%) |
| Mar 2023 | - | $122.11M(-19.2%) |
| Dec 2022 | $419.26M(+25.2%) | $151.09M(+27.7%) |
| Sep 2022 | - | $118.35M(-4.9%) |
| Jun 2022 | - | $124.39M(+0.2%) |
| Mar 2022 | - | $124.12M(+91.1%) |
| Dec 2021 | $334.89M(+73.9%) | $64.94M(-34.9%) |
| Sep 2021 | - | $99.80M(+7.1%) |
| Jun 2021 | - | $93.16M(+11.8%) |
| Mar 2021 | - | $83.34M(+29.2%) |
| Dec 2020 | $192.57M(+29.9%) | $64.51M(+23.5%) |
| Sep 2020 | - | $52.22M(+25.9%) |
| Jun 2020 | - | $41.48M(-2.2%) |
| Mar 2020 | - | $42.42M(+0.2%) |
| Dec 2019 | $148.29M(+29.1%) | $42.35M(+7.6%) |
| Sep 2019 | - | $39.37M(+0.7%) |
| Jun 2019 | - | $39.08M(+5.8%) |
| Mar 2019 | - | $36.94M(+22.5%) |
| Dec 2018 | $114.87M(+39.1%) | $30.16M(-2.9%) |
| Sep 2018 | - | $31.05M(+0.4%) |
| Jun 2018 | - | $30.94M(+4.0%) |
| Mar 2018 | - | $29.75M(+27.0%) |
| Dec 2017 | $82.60M(+10.2%) | $23.43M(-1.9%) |
| Sep 2017 | - | $23.89M(+19.6%) |
| Jun 2017 | - | $19.98M(-15.5%) |
| Mar 2017 | - | $23.66M(+75.4%) |
| Dec 2016 | $74.96M(-14.5%) | $13.49M(-30.1%) |
| Sep 2016 | - | $19.29M(-8.4%) |
| Jun 2016 | - | $21.07M(-23.8%) |
| Mar 2016 | - | $27.65M(+8.0%) |
| Dec 2015 | $87.70M(+47.7%) | - |
| Sep 2015 | - | $25.61M(+22.3%) |
| Jun 2015 | - | $20.94M(-4.8%) |
| Mar 2015 | - | $21.99M(+28.5%) |
| Dec 2014 | $59.38M(+23.6%) | $17.12M(+43.0%) |
| Sep 2014 | - | $11.97M(-25.7%) |
| Jun 2014 | - | $16.11M(+18.5%) |
| Mar 2014 | - | $13.60M(-15.0%) |
| Dec 2013 | $48.05M(-17.8%) | $16.00M(+54.0%) |
| Sep 2013 | - | $10.39M(-20.0%) |
| Jun 2013 | - | $12.99M(+61.2%) |
| Mar 2013 | - | $8.06M(-46.8%) |
| Dec 2012 | $58.42M(-15.6%) | $15.15M(-2.0%) |
| Sep 2012 | - | $15.46M(-6.2%) |
| Jun 2012 | - | $16.49M(-9.8%) |
| Mar 2012 | - | $18.27M(-0.8%) |
| Dec 2011 | $69.23M(-27.7%) | $18.42M(-6.6%) |
| Sep 2011 | - | $19.71M(-1.5%) |
| Jun 2011 | - | $20.01M(+8.4%) |
| Mar 2011 | - | $18.46M(-31.4%) |
| Dec 2010 | $95.70M(+8.4%) | $26.89M(+17.6%) |
| Sep 2010 | - | $22.86M(+28.4%) |
| Jun 2010 | - | $17.81M(-37.9%) |
| Mar 2010 | - | $28.67M(-27.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $88.33M(+5.5%) | $39.74M(+87.7%) |
| Sep 2009 | - | $21.18M(+57.2%) |
| Jun 2009 | - | $13.47M(-1.3%) |
| Mar 2009 | - | $13.65M(-43.5%) |
| Dec 2008 | $83.73M(-19.1%) | $24.17M(+35.1%) |
| Sep 2008 | - | $17.89M(+16.4%) |
| Jun 2008 | - | $15.37M(-35.6%) |
| Mar 2008 | - | $23.87M(-21.6%) |
| Dec 2007 | $103.52M(+94.6%) | $30.45M(-3.2%) |
| Sep 2007 | - | $31.45M(+54.1%) |
| Jun 2007 | - | $20.41M(+13.5%) |
| Mar 2007 | - | $17.98M(+48.1%) |
| Dec 2006 | $53.19M(+94.6%) | $12.14M(-30.2%) |
| Sep 2006 | - | $17.39M(+49.4%) |
| Jun 2006 | - | $11.64M(+34.5%) |
| Mar 2006 | - | $8.65M(+20.5%) |
| Dec 2005 | $27.33M(+23.7%) | $7.18M(-6.4%) |
| Sep 2005 | - | $7.68M(+34.5%) |
| Jun 2005 | - | $5.71M(+0.4%) |
| Mar 2005 | - | $5.69M(+4.9%) |
| Dec 2004 | $22.09M(+54.1%) | $5.42M(+0.1%) |
| Sep 2004 | - | $5.41M(+6.1%) |
| Jun 2004 | - | $5.10M(-6.6%) |
| Mar 2004 | - | $5.46M(+39.9%) |
| Dec 2003 | $14.33M(-23.4%) | $3.90M(+14.5%) |
| Sep 2003 | - | $3.41M(+4.8%) |
| Jun 2003 | - | $3.25M(+16.6%) |
| Mar 2003 | - | $2.79M(+1.9%) |
| Dec 2002 | $18.70M(+15.9%) | $2.74M(-19.9%) |
| Sep 2002 | - | $3.42M(-33.8%) |
| Jun 2002 | - | $5.16M(-8.1%) |
| Mar 2002 | - | $5.62M(+12.8%) |
| Dec 2001 | $16.14M(+22.8%) | $4.98M(+66.9%) |
| Sep 2001 | - | $2.98M(+11.5%) |
| Jun 2001 | - | $2.68M(-18.2%) |
| Mar 2001 | - | $3.27M(-13.2%) |
| Dec 2000 | $13.15M(+24.0%) | $3.77M(+121.2%) |
| Sep 2000 | - | $1.70M(-31.2%) |
| Jun 2000 | - | $2.48M(+8.2%) |
| Mar 2000 | - | $2.29M(+5136.4%) |
| Dec 1999 | $10.60M(-14.5%) | $43.70K(-98.1%) |
| Sep 1999 | - | $2.25M(-7.7%) |
| Jun 1999 | - | $2.44M(-6.6%) |
| Mar 1999 | - | $2.62M(+42.5%) |
| Dec 1998 | $12.40M(-6.8%) | $1.84M(-48.7%) |
| Sep 1998 | - | $3.58M(+9.5%) |
| Jun 1998 | - | $3.27M(-3.5%) |
| Mar 1998 | - | $3.39M(-0.4%) |
| Dec 1997 | $13.30M(+29.1%) | $3.40M(+17.2%) |
| Sep 1997 | - | $2.90M(-17.1%) |
| Jun 1997 | - | $3.50M(-2.8%) |
| Mar 1997 | - | $3.60M(+38.5%) |
| Dec 1996 | $10.30M(+10.8%) | $2.60M(-3.7%) |
| Sep 1996 | - | $2.70M(-10.0%) |
| Jun 1996 | - | $3.00M(+50.0%) |
| Mar 1996 | - | $2.00M(-16.7%) |
| Dec 1995 | $9.30M(+24.0%) | $2.40M(+9.1%) |
| Sep 1995 | - | $2.20M(+22.2%) |
| Jun 1995 | - | $1.80M(-41.9%) |
| Mar 1995 | - | $3.10M(+47.6%) |
| Dec 1994 | $7.50M | $2.10M(+10.5%) |
| Sep 1994 | - | $1.90M(-5.0%) |
| Jun 1994 | - | $2.00M(+25.0%) |
| Mar 1994 | - | $1.60M |
FAQ
- What is BioCryst Pharmaceuticals, Inc. annual total expenses?
- What is the all-time high annual total expenses for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. annual total expenses year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. quarterly total expenses?
- What is the all-time high quarterly total expenses for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
What is BioCryst Pharmaceuticals, Inc. annual total expenses?
The current annual total expenses of BCRX is $453.25M
What is the all-time high annual total expenses for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high annual total expenses is $453.25M
What is BioCryst Pharmaceuticals, Inc. annual total expenses year-on-year change?
Over the past year, BCRX annual total expenses has changed by +$18.13M (+4.17%)
What is BioCryst Pharmaceuticals, Inc. quarterly total expenses?
The current quarterly total expenses of BCRX is $146.50M
What is the all-time high quarterly total expenses for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high quarterly total expenses is $158.33M
What is BioCryst Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
Over the past year, BCRX quarterly total expenses has changed by +$15.38M (+11.73%)